Comparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal Cancer
Clinical trial NCT03288987 · COMPLETED
Trial details
- NCT number
- NCT03288987
- Sponsor
- AryoGen Pharmed Co.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-04
- Primary completion
- 2018-07-30
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.